Choose the Fast Lane for Your Viral Vector-Based Therapies
We understand that speed is key in viral vector production. An optimized upstream workflow relies on high-performing, scalable solutions.
Make confident decisions and accelerate your viral vector production.
Streamline Your AAV Manufacturing with a Novel Production Platform
Adeno-associated viruses (AAVs) have become a prominent vector for gene therapies, favored for their safety profile, low immunogenicity, and ability to drive long-lasting transgene expression. Unlock accelerated timelines and cost savings without compromising quality – download our whitepaper to learn how.
Explore Integrated Solutions to Accelerate Your Viral Vector Manufacturing
Leverage cutting-edge upstream viral vector manufacturing platforms optimized for enhanced AAV and LV productivity, accelerating your journey from process development to GMP manufacturing.
Expedite your AAV process
Discover effective strategies for process optimization with a medium tailored for HEK293
Scale up with confidence
Streamline process development with high-performing platforms for AAV and LV manufacturing
Boost your productivity
Maximize growth and productivity while improving the safety profile of insect cell-based processes
Join Our Expert-Led Webinars to Speed Up Your Viral Vector Manufacturing
Get on the List: Explore the Latest Advancements in Viral Vector Production
Stay ahead of new trends in biopharma and pharma manufacturing by subscribing to our newsletter. Discover the latest advancements, access recent webinars, and benefit from case studies and insights delivered by our technical experts.
如要继续阅读，请登录或创建帐户。
暂无帐户？